Stanford University
Showing 351-400 of 2,403 Results
-
Ilias Chrissochoidis
Affiliate, Medicine - Med/Stanford Prevention Research Center
BioIlias Chrissochoidis is a scholar, author, composer and pianist. He received his Ph.D. in Music from Stanford University where he has been teaching since 1997 (as Lecturer since 2005). A Geballe Dissertation Prize Fellow at Stanford's Humanities Center (2001-2), he was appointed a 2010 Fellow of the American Council of Learned Societies, and, in 2010-11, Kluge Fellow at the Library of Congress. In 2009, he became the first musicologist to be hired at an Economics department (University College London) and in 2015 he joined the Berlin Social Science Center. As a Research Associate at the Center for Economic Learning and Social Evolution, he engaged in innovative research on game theory applications in Wagner’s operas. A leading expert on Handel, he also has championed Greek composer Nicolas Astrinidis and introduced Spyros P. Skouras in American and film historiography, editing his memoirs. Chrissochoidis has received over 30 grants and fellowships from world-renowened universities and research centers, professional societies, private foundations, and the Greek state. He has authored more than 50 research articles and essays, which can be found in leading musicological journals. In recognition of his musicological activity, the Academy of Athens awarded him a special commendation in 2005. As an author, Chrissochoidis has written six non-academic books in Greek and has published dozens of articles on educational, social, and political issues in the Stanford Daily, the Chronicle of Higher Education, and in the Greek newspapers Ta Nea, Kathimerini, Sunday Vima, and Vima Ideon. Composing music since his teens, he has written extensively for the piano and has released four albums of instrumental music. His listening-oriented course "A practical introduction to music theory and harmony" has been offered through Stanford Continuing Studies since 2005.
-
Antonios Chronopoulos
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors
-
Alvina Dor-Yan Chu
Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioAlex Weihan Chu, M.D. serves as a Clinical Assistant Professor at Stanford School of Medicine and is the Associate Chief Medical Officer and Vice President of Quality, Health Equity, and Clinical Affairs at Stanford Health Care Tri-Valley.
Dr. Chu has been a dedicated member of SHC Tri-Valley since 2015, joining as a Hospital Medicine physician after completing his residency at Stanford Hospital. He is board-certified in Internal Medicine and Clinical Informatics. Since 2016, he has served as the Medical Informatics Director, a role he continues to oversee, ensuring that technology enhances clinical workflows and patient care.
Dr. Chu has held multiple leadership roles, including serving on the Medical Executive Committee and as Vice Chief of Medicine. He previously served as Associate Chief Medical Officer for Patient Safety, Infection Control & Accreditation, Regulatory & Licensing, where he played a key role in supporting Joint Commission surveys, ensuring CDPH compliance, and leading hospital safety initiatives to address regulatory findings.
In 2024, Dr. Chu transitioned to his current role, the Associate Chief Medical Officer and Vice President for Quality, Health Equity, and Clinical Affairs where he is responsible for coordinating a comprehensive system of quality monitoring and improvement to achieve excellent patient care. He works closely with Kathleen Carrothers, Senior Director of Quality Management and Performance Improvement, to oversee clinical outcomes, data management, and performance improvement initiatives. He also leads health equity efforts and manages physician agreements, ensuring sustained high-quality care and strategic physician engagement.
Dr. Chu brings expertise in physician engagement, clinical oversight, clinical informatics, and quality improvement. His experience in driving multi-disciplinary change and advancing health equity to aligns with the hospital’s mission and vision.
Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring the latest advancements in technology. -
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
On Partial Leave from 02/01/2026 To 08/31/2026Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
-
Jonathan Wayne Chun
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
Current Role at StanfordInpatient Rotation Director for the VA
-
Lorinda Chung
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.
-
Daniel Clark, MD, MPH
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.
Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.
Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.
Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association. -
John Clarke
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. John Clarke recently joined the Gastroenterology & Hepatology Division at Stanford University as Director of the Esophageal Program. He previously spent 17 years in Baltimore, including 9 years on the faculty at Johns Hopkins University where he was an Associate Professor and at various times Director of Esophageal Motility, Director of Gastrointestinal Motility, Clinical Director of the Johns Hopkins Center for Neurogastroenterology, and Clinical Director of the Gastroenterology & Hepatology Division at Johns Hopkins Bayview Medical Center.
His career has combined research, education and clinical care. His clinical areas of expertise include achalasia, dysphagia, eosinophilic esophagitis, esophageal dysmotility, gastroesophageal reflux disease, gastroparesis, GI-manifestations of scleroderma and GI dysmotility. While at Johns Hopkins University, he was inducted into The Miller-Coulson Academy for Clinical Excellence, an institutional honor society for master clinicians at the time limited to 50 members across the entire university.
From an education standpoint, he has lectured in over a dozen countries, authored over 25 textbook chapters and serves on the educational affairs committee of the American College of Gastroenterology. He has also won several major teaching awards, including The Johns Hopkins University Alumni Association Award for Excellence in Teaching, given to one faculty member per year in the entire School of Medicine.
His research has focused on optimization and characterization of diagnostic studies to evaluate motility disorders, as well the relationship between therapeutic endoscopic techniques and treatment of motility disorders. He was an investigator on the NIH Gastroparesis Consortium and is also a former recipient of the AGA Don Castell Award. -
Michael F. Clarke, M.D.
Karel H. and Avice N. Beekhuis Professor of Cancer Biology
Current Research and Scholarly InterestsDr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.
-
Shoa L. Clarke, MD, PhD
Assistant Professor of Medicine (Stanford Prevention Research Center) and of Pediatrics (Cardiology)
BioDr. Clarke is a preventive cardiologist and a physician-scientist focused on disease prevention. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties. His research is focused on 1) understanding complex disease genetics in diverse populations, 2) integrating monogenic and polygenic risk with clinical risk, 3) large-scale phenotyping using the electronic health record and medical images. His clinical practice focuses on identifying risk factors for cardiovascular disease with the goal of promoting health and longevity through evidence-based personalized treatment. He is interested in developing family-centric approaches for the treatment of adults and children carrying genetic risk for disease.
-
William Clusin, MD
Associate Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.
-
Nathaniel Lee Coggins
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Clinical Assistant Professor, Emergency MedicineBioNathaniel Coggins, M.D. is a palliative care and emergency medicine physician specializing in the implementation and dissemination of palliative care in the emergency department setting. Dr. Coggins holds dual-appointments as Clinical Assistant Professor in the Departments of Medicine and Emergency Medicine and is the Program Director for Stanford Emergency Palliative Care.
Dr. Coggins received his medical degree from the David Geffen School of Medicine at UCLA in 2019, where he was a recipient of the David Geffen Medical Scholarship. He completed his emergency medicine residency training at UCLA and hospice and palliative medicine fellowship training at the University of Utah. Dr. Coggins joined Stanford University as faculty in 2024, where he is an attending physician on the inpatient palliative care service and in the adult emergency department. -
Stanley N. Cohen, MD
Kwoh-Ting Li Professor in the School of Medicine, Professor of Genetics and of Medicine
On Partial Leave from 06/04/2025 To 07/16/2026Current Research and Scholarly InterestsWe study mechanisms that affect the expression and decay of normal and abnormal mRNAs, and also RNA-related mechanisms that regulate microbial antibiotic resistance. A small bioinformatics team within our lab has developed knowledge based systems to aid in investigations of genes.
-
Elana Trubowitch Cohn
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Elana Cohn (She/Her) is a board-certified Family Physician, with a love for caring for the whole person and the entire family.
She completed her bachelor's degree in Neuroscience and Behavior at Barnard College, after which she worked as a Health Outreach coordinator on a mobile medical van providing care to the homeless population in NY, which sparked her love for primary care. She received her medical degree at Tel aviv University, and completed her residency at Mount Sinai and the Institute for Family Health.
Her practice spans care for all ages, with an emphasis on care for marginalized populations, reproductive health, office based-procedures, and teaching. She is passionate about integrating mental health care and reproductive justice into general practice, and making care for her patients as comprehensive as possible.
Outside of the office, she loves to travel and explore new places, dance her heart out, and spend time with her family. -
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
On Partial Leave from 10/01/2025 To 04/15/2026Current Research and Scholarly InterestsMulti- modality treatment of Head and Neck Cancer
Phase 1 clinical trials -
Caitlin Contag
Clinical Scholar, Medicine - Pulmonary, Allergy & Critical Care Medicine
Postdoctoral Scholar, Pulmonary and Critical Care MedicineCurrent Research and Scholarly InterestsEmerging pathogens, high-consequence pathogens, critical care in resource limited settings, early interventions for sepsis, marginalized patient populations, sexually transmitted diseases, planetary health
-
Marimar Contreras Nieves
Clinical Scholar, Medicine - Nephrology
Postdoctoral Scholar, NephrologyBioI am currently in my second year of nephrology fellowship, working on a Masters in clinical research and epidemiology, and also doing postdoctoral research on a U2C-TL1. During my training I have worked on clinical research focused on environmental risk factors and health care barriers that can initiate or accelerate the development and progression of kidney disease. My goal is to reach disadvantaged populations and help reduce the gaps in health that may stem from their vulnerability to determinantal environmental exposures. My projects have included investigating chronic kidney disease of uncertain etiology, with particular interest in California’s Central Valley.
-
John P. Cooke, MD, PhD
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsOur translational research program in vascular regeneration is focused on generating and characterizing vascular cells from human induced pluripotential stem cells. We are also studying the therapeutic application of these cells in murine models of peripheral arterial disease. In these studies we leverage our longstanding interest in endothelial signaling, eg by nitric oxide synthase (NOS) as well as by nicotinic cholinergic receptors (nAChR).
-
Allen Cooper
Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsI have had a long standing interest in the liver's role in cholesterol and lipid metabolism. In the past this was focused on laboratory studies but currently involves human studies as part of my patient care responsibilities. In particular I am interested in the role of NAFLD (non-alcoholic fatty liver disease) in patients with Hepatitis C aand in post liver transplant patients.
-
Joseph David Cooper
Clinical Assistant Professor (Affiliated), Medicine - Med/Infectious Diseases
BioJoseph David Cooper attended Bucknell University for his undergraduate degree with a dual major in Biology and Philosophy. He graduated from St. George’s University School of Medicine and went on to complete his Internal Medicine residency at Geisinger Medical Center in Danville, Pennsylvania. He remained at Geisinger for an additional year as Chief Resident in Internal Medicine with a focus on teaching and the education of trainees. He completed his Infectious Diseases fellowship at Montefiore Medical Center-Albert Einstein College of Medicine in the Bronx, New York. He is board certified in both Internal Medicine and Infectious Disease.
He began working at Santa Clara Valley Medical Center primarily in the PACE (Partners in AIDS Care and Education) and Infectious Diseases Clinics in July 2019. He has an active outreach HIV clinic at Valley Health Center in Gilroy, California once a month which maintains a regional presence for excellence in HIV care. He sees outpatients with general infectious diseases and provides inpatient infectious diseases consultation at Santa Clara Valley Medical Center, the main quaternary referral hospital for the Santa Clara Valley Healthcare system. He is actively involved in the teaching and training of Stanford University Infectious Diseases fellows, Internal Medicine residents from his home institution and Kaiser Permanente Santa Clara. Dr. Cooper holds an appointment of Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine in the division of Infectious Diseases & Geographic Medicine and department of Medicine since 2020.
Dr. Cooper is an active member of the American College of Physicians, WikiGuidelines (PWID and Bacteremia guidelines), Infectious Diseases Society of America, and HIV Medicine Association. He volunteers his time and energy within these international professional organizations previously serving on workgroups surrounding education, mentoring of trainees and as an ad hoc reviewer for infectious diseases and general internal medicine journals. His professional interests are broad and include HIV/AIDS, opportunistic infections, sexually transmitted infections, with a special interest in mycology and fungal infections. He is widely published in a variety of academic journals collaborating with colleagues in all parts of the world. Administratively, Dr. Cooper has held numerous leadership positions, previously serving as Associate Medical Director of the PACE Clinic from 2021 to 2023. Currently, Dr. Cooper holds a leadership position serving on the executive board of Valley Physicians Group (VPG), an organization representing over 400 physicians, dentists and podiatrists at his current institute, focusing on physician advocacy, excellence and organization. Dr. Cooper is passionate about providing high quality, evidence-based care to people living with HIV and AIDS. He uses his professional expertise, passion and energy to ensure that his patients remain as well and healthy as possible.
Outside of medicine and work, you can find Dr. Cooper spending time with his wife and two daughters - hiking and exploring the Bay Area and beyond, listening to all types of music with a particular interest in live music, gardening, nature photography, cooking new recipes, exercising and playing sports. -
Steven M. Corsello
Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur laboratory operates at the intersection of functional genomics and chemical biology, with the goal of advancing novel molecular mechanisms of cancer inhibition to clinical use. We aim to 1) leverage phenotypic screening and functional genomics to determine novel anti-cancer mechanisms of small molecules, 2) develop new targeted therapy approaches against solid tumors, and 3) build a comprehensive community resource for drug repurposing discovery.
-
Helio Costa
Affiliate, Biomedical Informatics (BMI) graduate training program
BioHelio Costa, PhD, is a medical geneticist specializing in oncology, genomics, computational biology, data science, artificial intelligence, and product development. His work focuses on developing new cancer therapies and medical software to improve cancer patient care. He currently serves as Senior Medical Director and Head of Molecular Therapeutics & Drug Development at Natera and is an Adjunct Clinical Assistant Professor in the Department of Pathology at Stanford Medical School.
Dr. Costa’s research spans the entire drug development pipeline, from discovery to FDA-approved therapies. He leads efforts in developing innovative cancer treatments by integrating advanced genomics, computational biology, and AI-driven methodologies. His team focuses on the creation of targeted molecular therapeutics, using large-scale genetic data to identify novel treatment pathways and predict patient responses. In addition to drug discovery, Dr. Costa oversees the clinical trials necessary for validating these therapies, ensuring they meet rigorous standards for safety and efficacy. Furthermore, he manages the product development and commercialization process, guiding new treatments from initial research through to market-ready, FDA-approved cancer therapies.
In addition to his therapeutic work, Dr. Costa has led the development and implementation of genetic diagnostic tests and clinical algorithms used to support therapeutic decisions at Stanford Health Care. His contributions include the creation of DNA and RNA cancer diagnostic tests, as well as algorithms that analyze large-scale laboratory datasets and electronic medical records to predict patient outcomes. As a co-investigator with the NIH Clinical Genome Resource (ClinGen) Consortium, Dr. Costa oversaw developing FDA-recognized medical software used by healthcare providers, researchers, and biotech companies to assess the clinical relevance of genes and mutations.
He is the founding director of the Stanford Clinical Data Science Fellowship, where post-doctoral medical fellows engage in interdisciplinary clinical research and implement real-world health data solutions within Stanford Health Care. Dr. Costa is also an Attending Medical Geneticist for the Molecular Genetic Pathology Laboratory at Stanford Health Care, where he previously served as Assistant Lab Director.
Dr. Costa holds a BS in Genetics from the University of California, Davis, a PhD in Genetics from Stanford University School of Medicine, and completed his ABMGG Clinical Molecular Genetics and Genomics fellowship training at Stanford University School of Medicine.
